✦ LIBER ✦

PDB26 COMPARATIVE EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 AND INSULIN GLARGINE IN A SUB-POPULATION OF POORLY CONTROLLED PATIENTS WITH TYPE-2 DIABETES RECEIVING ORAL ANTIDIABETIC AGENTS

✍ Scribed by D Cobden; L Nicklasson; P Raskin; A Garber; JA Ray; W Valentine; A Palmer; S Roze

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin therapy in type 2 diabetes patie

✍ J. A. Ray; W. J. Valentine; S. Roze; L. Nicklasson; D. Cobden; P. Raskin; A. Gar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Cost-Effectiveness of Switching to Bipha

✍ Kyoung Hee Lee; Se Jin Seo; Jayne Smith-Palmer; James L. Palmer; Jeremy White; W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB20 BIPHASIC INSULIN ASPART 30 VERSUS

✍ AJ Palmer; M Lammert; WJ Valentine; JA Ray; AS Brandt; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PDB30 A MODELLED COST-EFFECTIVENESS ANAL

✍ L Stechemesser; R Weitgasser; M Hofmann; M Aagren; R Mihaljev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB